Total trials
226
Active
39
Phase 3
6
Total enrollment
26,765
Pipeline matrix
Showing 15 of 15 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Low-Dose Cannabidiol | — | — | — | — | — | 1 | |
| Moderate-Dose Cannabidiol | — | — | — | — | — | 1 | |
| Yohimbine + Hydrocortisone | — | — | — | — | — | 3 | |
| Morphine | — | — | — | — | — | 1 | |
| Alprazolam | — | — | — | — | — | 1 | |
| Cannabidiol | — | — | — | — | — | 1 | |
| Etanercept | — | — | — | — | — | 1 | |
| Tetrahydrocannabinol | — | — | — | — | 2 | ||
| Ondansetron 8mg | — | — | — | — | — | 1 | |
| Cannabidiol (CBD) only | — | — | — | — | — | 1 | |
| Delta-9-tetrahydrocannabinol (THC) only | — | — | — | — | — | 1 | |
| THC:CBD 1:1 | — | — | — | — | — | 1 | |
| Emicizumab | — | — | — | — | — | 1 | |
| FVIII | — | — | — | — | — | 1 | |
| 1-(2-[+F]fluoroethyl)-L-tryptophan | — | — | — | — | — | 1 |
Next readouts
- 2025-08-01
- 2026-09
- 2026-12
- 2027-08-31
- 2028-12
- 2029-01
- 2030-08-31
- 2030-12-31
- 2031-09
Top conditions
- Hypertension10
- Heroin Dependence7
- Post Traumatic Stress Disorder6
- Opioid-Related Disorders6
- Multiple Sclerosis6
- Marijuana Abuse6
- Type 1 Diabetes5
- Cocaine Abuse or Dependence4
Frequently asked questions about Wayne State University
- How many clinical trials does Wayne State University have on ClinicalTrials.gov?
- Wayne State University is listed as the lead sponsor on 226 clinical trials in ClinicalTrials.gov, 39 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Wayne State University's trials are in Phase 3?
- 6 of Wayne State University's trials are in Phase 3, spread across 15 active drug programs.
- What therapeutic areas does Wayne State University focus on?
- Wayne State University's most-studied conditions on ClinicalTrials.gov are Hypertension, Heroin Dependence, Post Traumatic Stress Disorder, Opioid-Related Disorders, Multiple Sclerosis.
- When are Wayne State University's next clinical trial readouts?
- Wayne State University has 9 upcoming primary-completion readouts tracked here; the soonest is “Ondansetron Use for Preventing Pruritus in Patients Undergoing Cesarean Section”, expected around 2025-08-01.